Meeting
2015 Genitourinary Cancers Symposium
Incidence and predictors of upgrading and upstaging among 10,000 contemporary patients with low-risk prostate cancer.
Authors
Kathryn Tindell Dinh
Harvard Medical School, Boston, MA
Kathryn Tindell Dinh , Brandon Arvin Virgil Mahal , David R. Ziehr , Vinayak Muralidhar , Yu-Wei Chen , Vidya Bhavani Viswanathan , Michelle Daniel Nezolosky , Clair Beard , Toni K. Choueiri , Neil E. Martin , Peter F. Orio , Christopher Sweeney , Quoc-Dien Trinh , Paul Linh Nguyen
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
General Poster Session A: Prostate Cancer
Track
Prostate Cancer
Sub Track
Prostate Cancer - Localized Disease
Citation
J Clin Oncol 33, 2015 (suppl 7; abstr 32)
DOI
10.1200/jco.2015.33.7_suppl.32
Abstract #
32
Poster Bd #
B24
Abstract Disclosures
Similar Posters
Poster
2021 Genitourinary Cancers Symposium
PSA velocity to predict clinical progression in African American and non-Hispanic White patients with low-risk prostate cancer undergoing active surveillance.
First Author: Juan Javier-Desloges
Poster
2021 Genitourinary Cancers Symposium
p2PSA-associated parameters are significant predictors of reclassification of first-year protocol biopsy on active surveillance for early-stage prostate cancer patients: From the PRIAS-JAPAN study.
First Author: Takuma Kato
Poster
2019 ASCO Annual Meeting
Assessment of 2,000 patients presenting to a multidisciplinary prostate cancer clinic in the United Kingdom.
First Author: Pandora Rudd
Poster
2018 Genitourinary Cancers Symposium
Development and pilot testing of a decision support intervention for men with prostate cancer.
First Author: June M. Chan